C260-2905 Screening compound: ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}acetamido)benzoate

C260-2905 Screening compound: ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}acetamido)benzoate
C260-2905 Screening compound: ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}acetamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2905
ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}acetamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2905

Molecular Formula

C32H28N4O7 (C32 H28 N4 O7)

Compound Name

ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}acetamido)benzoate

IUPAC name

ethyl 4-(2-{3-[4-({[(furan-2-yl)methyl]carbamoyl}methyl)phenyl]-24-dioxo-1234-tetrahydroquinazolin-1-yl}acetamido)benzoate

SMILES

CCOC(c(cc1)ccc1NC(CN(c(cccc1)c1C(N1c2ccc(CC(NCc3ccco3)=O)cc2)=O)C1=O)=O)=O

InChI

InChI=1S/C32H28N4O7/c1-2-42-31(40)22-11-13-23(14-12-22)34-29(38)20-35-27-8-4-3-7-26(27)30(39)36(32(35)41)24-15-9-21(10-16-24)18-28(37)33-19-25-6-5-17-43-25/h3-17H,2,18-20H2,1H3,(H,33,37)(H,34,38)

InChI Key

UNSPCTCRLGMBAI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14738980

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

580.6

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

3.636

Distribution Coefficient, logD

3.636

Water Solubility, LogSw

-3.87

Polar Surface Area

106.507

Acid Dissociation Constant (pKa)

11.25

Base Dissociation Constant (pKb)

-0.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.60

C260-2905 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C260-2905 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2905?
Check Price and Availability of C260-2905, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2905 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2905
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2905
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2905 available by request